|
CHALK up
another victory for the big pharmaceutical companies
with the expected passage of a watered-down
cheaper-medicines bill.
We can
understand the frustration of Iloilo Rep. Ferjenel Biron,
the principal author of the House version of the bill.
He laments what he calls the “drastic weakening” of his
proposed measure with the removal of its two key
provisions: that physicians shall prescribe only generic
drugs to their patients, and that the government shall
set up a drug-price regulatory board.
With
these two vital provisions—the “heart and soul” of the
bill, as Biron describes it—expunged, what remains, in
fact, is just the title.
In other
words, the cheaper medicines bill will mean exactly the
opposite—and the poor, in particular, will suffer the
most because they will be denied access to affordable
medicine.
So it’s
absolutely correct that Biron and other legislators who
support the idea of cheaper medicines are now
contemplating not signing the draft report by the House
panel before the bicameral committee meeting on the
measure.
And if
the Senate will insist on a final version that also
excludes the generics-only provision and the price
regulatory board, then we can very well jettison any
hope that Filipinos can gain ready access to cheaper
medicines.
This is
truly unfortunate because other countries such as India
have been able to go beyond the stranglehold of the
multinational pharmaceutical companies and produce
medicines for a wide variety of illnesses within the
reach of their people.
That
raises the question: Which is more important, the health
and well-being of the masses of our people, or the
profit levels of the mostly foreign pharmaceutical
companies operating in the country?
Sen. Mar
Roxas II, the main author of the cheaper-medicines bill
in the Senate, should tell us exactly if we can expect
cheaper medicines or not in the near future.
If not,
that can only mean one thing: The huge pharmaceutical
companies are certainly no pushovers in the lobbying
game, and can get what they want from this government,
at the expense of the poor and the sick.
Bloated
IF the
cheaper-medicines bill that will finally be signed into
law is an emasculated one that perpetuates the regime of
high prices of lifesaving drugs, what is happening in
the bureaucracy is just the opposite. It gets bigger and
bigger, and its bloated character is nowhere more in
evidence than in the Office of the President, where the
operative principle seems to be: the more the merrier.
Result:
A top-heavy structure that eats up scarce government
resources.
A study
conducted by the Philippine Center for Investigative
Journalism reveals that President Arroyo already has
under her 27 Cabinet-rank secretaries, as well as the
executive directors or heads of 38 other executive
agencies, commissions and committees under the Office of
the President. Apart from them, the President has an
adviser, assistant or consultant for every region and
super-region in the country, as well as for specific
functions, such as jobs generation, strategic projects,
revenue enhancement, new government centers, military
affairs, police affairs, interior and local government
matters, transnational crimes, culture and entertainment
industry, among many others. There’s even a presidential
consultant on Muslim royalty affairs.
Executive Secretary Eduardo Ermita asserts that, except
for one or two, the Arroyo advisers, assistants and
consultants numbering more than 50 do not receive any
compensation. But still, the offices and staff of these
excess advisers, assistants and consultant ate up about
P122 million of the government budget yearly, which, by
every reckoning, is a big amount that can very well be
put to better use.
One
question that begs for answers is whether these
officials are truly experts who provide valuable advice
to the President in their field, or they’re there
because of political expediency. Malacańang should tell
the people exactly what have been the real
accomplishments of these appointees.
Pending
before Congress is the career executive system bill
which gives the Civil Service Commission (CSC) the power
to appoint people to rank, from which the President
would choose whom to assign where. This would allow the
CSC to check appointments. Under the proposed measure,
Cabinet secretaries would be chosen by the directors of
each agency, with the power to choose the undersecretary
and assistant secretary left to the President. This is a
step in the right direction, as it would ensure
competence and fitness for public office. It’s about
time key public officials serve on the basis of merit,
and not on the “pleasure of the President.” |